Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1641 1644 1645 1671
This examiner grants 59% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17630706 | MATERIALS AND METHODS FOR POLYMERIC ANTIBODY RECEPTOR TARGETING | Non-Final OA | JANSSEN BIOTECH, INC. |
| 18448519 | TEST METHOD AND TEST KIT FOR ADULT STILL'S DISEASE | Non-Final OA | Canon Kabushiki Kaisha |
| 18553523 | CLASSIFICATION OF NEUROLOGICAL OR PSYCHIATRIC DISEASE MANIFESTATIONS USING MULTI-DIMENSIONAL CEREBROSPINAL FLUID ANALYSIS | Non-Final OA | The Regents of the University of California |
| 18512522 | MODULATING BONE MORPHOGENIC PROTEIN (BMP) SIGNALING IN THE TREATMENT OF ALZHEIMER'S DISEASE | Final Rejection | The Board of Trustees of the Leland Stanford Junior University |
| 18550537 | METHODS FOR TREATING CANCER WITH ANTI-ILT3 ANTIBODIES | Non-Final OA | Merck Sharp & Dohme LLC |
| 18229117 | Methods of Treating Metastatic Castration-Resistant Prostate Cancer with Bispecific Anti-PSMA x Anti-CD28 Antibodies in Combination with Anti-PD-1 Antibodies | Non-Final OA | Regeneron Pharmaceuticals, Inc. |
| 16863800 | METHODS FOR TREATING OR PREVENTING ASTHMA BY ADMINISTERING AN IL-33 ANTAGONIST | Final Rejection | REGENERON PHARMACEUTICALS, INC. |
| 17310262 | METAL CHELATOR COMBINATION THERAPY FOR THE TREATMENT OF CANCER | Final Rejection | Board of Regents, The University of Texas System |
| 17997298 | COMPOSITIONS AND METHODS OF ADAMTS13 CHIMERIC AUTOANTIBODY RECEPTOR CELLS | Non-Final OA | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA |
| 18267257 | T CELL RECRUITING POLYPEPTIDES BASED ON TCR ALPHA/BETA REACTIVITY | Non-Final OA | Sanofi |
| 18548823 | Compositions and Methods for Treating Skeletal Muscle Disease | Non-Final OA | Yale University |
| 18223730 | COMPOSITIONS AND METHODS FOR TREATING A DISEASE | Final Rejection | RAMOT AT TEL AVIV UNIVERSITY LTD. |
| 17907039 | CORONA NUCLEOCAPSID ANTIGEN FOR USE IN ANTIBODY-IMMUNOASSAYS | Final Rejection | Roche Diagnostics Operations, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy